De Witte Jan
SEC CIK 1776929 · EDGAR
BoughtSold
Most active insiders at RMD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Farrell Michael J. | COB, CEO, Dir | — | $15.74M |
| 2 | FARRELL PETER C | Dir | — | $5.01M |
| 3 | Sandercock Brett | CFO | — | $2.79M |
| 4 | De Witte Jan | Dir | — | $645.9K |
| 5 | Rider Michael J | Gbl GC | — | $64.7K |
| 6 | Mowad-Nassar Nicole | Dir | — | — |
| 7 | Hernandez John | Dir | — | — |
| 8 | Tan Desney | Dir | — | — |
| 9 | DelOrefice Christopher | Dir | — | — |
| 10 | Leong Justin | Chief Product Off | — | — |
Transactions 30
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-26 | 2025-11-25 | RMD | ResMed| | De Witte Jan | Dir | S - Sale | $255.00 | -2,055 | 4,261 | -33% | -$524.0K | |
| 2025-11-24 | 2025-11-20 | RMD | ResMed| | De Witte Jan | Dir | A - Grant | $0.00 | +1,073 | 6,316 | +20% | $0 | |
| 2025-11-13 | 2025-11-11 | RMD | ResMed| | De Witte Jan | Dir | F - Tax | $250.10 | -76.45 | 5,242 | -1% | -$19.1K | |
| 2025-11-13 | 2025-11-11 | RMD | ResMed| | De Witte Jan | Dir | S - Sale | $250.25 | -487 | 5,319 | -8% | -$121.9K | |
| 2025-05-22 | 2025-05-20 | RMD | ResMed| | De Witte Jan | Dir | S - Sale | $243.47 | -2,000 | 5,806 | -26% | -$486.9K | |
| 2024-11-22 | 2024-11-20 | RMD | ResMed| | De Witte Jan | Dir | A - Grant | $0.00 | +1,083 | 7,806 | +16% | $0 | |
| 2024-11-14 | 2024-11-12 | RMD | ResMed| | De Witte Jan | Dir | S - Sale | $248.81 | -796 | 6,723 | -11% | -$198.1K | |
| D | 2024-11-04 | 2024-11-01 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | De Witte Jan | Pres, CEO, Dir | M - OptEx | $0.00 | +9,814 | 28.2K | +53% | $0 |
| D | 2024-11-04 | 2024-11-01 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | De Witte Jan | Pres, CEO, Dir | F - Tax | $19.28 | -4,262 | 23.9K | -15% | -$82.2K |
| A | 2024-05-22 | 2024-05-15 | RMD | ResMed| | De Witte Jan | Dir | S - Sale | $218.29 | -360 | 7,519 | -5% | -$78.6K |
| 2024-05-17 | 2024-05-15 | RMD | ResMed| | De Witte Jan | Dir | S - Sale | $218.29 | -360 | 7,519 | -5% | -$78.6K | |
| D | 2024-03-13 | 2024-03-11 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | De Witte Jan | Pres, CEO, Dir | M - OptEx | $0.00 | +205 | 18.6K | +1% | $0 |
| D | 2024-03-13 | 2024-03-11 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | De Witte Jan | Pres, CEO, Dir | F - Tax | $36.22 | -205 | 18.4K | -1% | -$7,425 |
| D | 2024-03-12 | 2024-03-10 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | De Witte Jan | Pres, CEO, Dir | M - OptEx | $0.00 | +346 | 18.7K | +2% | $0 |
| D | 2024-03-12 | 2024-03-10 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | De Witte Jan | Pres, CEO, Dir | F - Tax | $36.73 | -346 | 18.4K | -2% | -$12.7K |
| D | 2024-01-19 | 2024-01-18 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | De Witte Jan | Pres, CEO, Dir | F - Tax | $42.39 | -597 | 18.4K | -3% | -$25.3K |
| D | 2024-01-19 | 2024-01-18 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | De Witte Jan | Pres, CEO, Dir | M - OptEx | $0.00 | +597 | 18.9K | +3% | $0 |
| 2023-11-20 | 2023-11-16 | RMD | ResMed| | De Witte Jan | Dir | A - Grant | $0.00 | +1,768 | 7,879 | +29% | $0 | |
| D | 2023-11-03 | 2023-11-01 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | De Witte Jan | Pres, CEO, Dir | F - Tax | $36.85 | -4,262 | 18.4K | -19% | -$157.1K |
| D | 2023-11-03 | 2023-11-01 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | De Witte Jan | Pres, CEO, Dir | M - OptEx | $0.00 | +9,814 | 22.6K | +77% | $0 |
| DA | 2023-10-13 | 2023-03-11 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | De Witte Jan | Pres, CEO, Dir | M - OptEx | $0.00 | +205 | 5,211 | +4% | $0 |
| DA | 2023-10-13 | 2023-03-11 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | De Witte Jan | Pres, CEO, Dir | F - Tax | $52.87 | -205 | 5,006 | -4% | -$10.8K |
| 2023-06-02 | 2023-06-01 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | De Witte Jan | Pres, CEO, Dir | P - Purchase | $38.50 | +7,792 | 12.8K | +156% | +$300.0K | |
| D | 2023-03-14 | 2023-03-11 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | De Witte Jan | Pres, CEO, Dir | F - Tax | $52.87 | -3,842 | 5,006 | -43% | -$203.1K |
| 2023-02-15 | 2023-02-13 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | De Witte Jan | Pres, CEO, Dir | A - Grant | $0.00 | +8,848 | 8,848 | New | $0 | |
| D | 2023-01-19 | 2023-01-18 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | De Witte Jan | Pres, CEO, Dir | F - Tax | $54.78 | -431 | 0 | -100% | -$23.6K |
| D | 2023-01-19 | 2023-01-18 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | De Witte Jan | Pres, CEO, Dir | M - OptEx | $0.00 | +431 | 431 | New | $0 |
| 2022-11-21 | 2022-11-16 | RMD | ResMed| | De Witte Jan | Dir | A - Grant | $0.00 | +1,122 | 6,111 | +22% | $0 | |
| 2021-11-22 | 2021-11-18 | RMD | ResMed| | De Witte Jan | Dir | A - Grant | $0.00 | +956 | 4,989 | +24% | $0 | |
| 2021-11-15 | 2021-11-11 | RMD | ResMed| | De Witte Jan | Dir | F - Tax | $259.47 | -104 | 4,033 | -3% | -$27.0K |
Purchase Sale Sale after option exercise All abbreviations